Anyone else notice in the quarterly commentry that next quarter's Retiserst royalties (approx $300k) will be the last for a couple of years. Bausch and Lomb will retain the next $5.7m worth of royalties under the licence agreement. Well that was news to me. Where will any income come from now other than maybe a small trigger payment from Pfizer? More capital raising has to be on the cards. I bought in at 27c and have been happy to hold in the low 20s but sub 20 is now starting to worry me. Psivida is also cherry ripe to be hammered down further by end of FY selling pressure to capitalise losses. And why wouldn't you after the share price capitulation this FY?
PSD Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.